Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique?

Izabela Domagała, Marta Miszczuk, Katarzyna Luczak-Wozniak, Marta Dabrowska, Rafal Krenke
European Respiratory Journal 2019 54: PA4233; DOI: 10.1183/13993003.congress-2019.PA4233
Izabela Domagała
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: izabela-domagala@wp.pl
Marta Miszczuk
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarzyna Luczak-Wozniak
1Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Dabrowska
2Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warszawa, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rafal Krenke
2Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warszawa, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: proper inhalation technique is essential for effective therapy in asthma and chronic obstructive pulmonary disease (COPD). The use of the smallest possible number of different inhalers (particularly, the avoidance of the concomitant use of metered dose inhalers, MDI, and dry powder inhalers, DPI) is recommended to minimize the risk of inhaler mishandling.

Aim: to analyze the number of inhalation errors in relation to the number of inhalers used by patients with asthma and COPD

Methods: the number, type of inhalers and inhalation errors was evaluated in consecutive patients with asthma and COPD using > 1 inhaler on a regular basis.

Results: 110 patients (55 asthma, 55 COPD; 59F, 51M; median age 67 years, median disease duration 10 years) were included. The median number of different inhalers per patient was 3 (IQR 2-3); 70 patients (64%) used ≥3 inhalers. 84 patients (76%) used MDI and DPI. The median number of mistakes in inhalation technique per patient was 4 (IQR 2-6). The number of inhalers used tended to correlate with the number of inhalation errors, however this correlation did not reach statistical significance (r=0,2, p=0.056). We did not find differences in number of used inhalers between patients, who made <3 and ≥ 3 inhalation errors.

Conclusions: despite the current recommendations on inhaled therapy, the majority of patients with asthma and COPD still use more than two types of inhalers on a regular basis. The number of inhalers used was not related with the number of inhalation errors in our investigated group.

  • Asthma - management
  • COPD - management
  • Airway management

Footnotes

Cite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA4233.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2019
Previous
Back to top
Vol 54 Issue suppl 63 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique?
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique?
Izabela Domagała, Marta Miszczuk, Katarzyna Luczak-Wozniak, Marta Dabrowska, Rafal Krenke
European Respiratory Journal Sep 2019, 54 (suppl 63) PA4233; DOI: 10.1183/13993003.congress-2019.PA4233

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Does the number of inhalers used by patients with asthma and COPD determine number of mistakes in inhalation technique?
Izabela Domagała, Marta Miszczuk, Katarzyna Luczak-Wozniak, Marta Dabrowska, Rafal Krenke
European Respiratory Journal Sep 2019, 54 (suppl 63) PA4233; DOI: 10.1183/13993003.congress-2019.PA4233
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial
  • Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma
  • Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment
Show more Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society